Ultra-low-dose twice-daily aspirin improves haemostasis and maintains platelet inhibition in acute coronary syndrome patients receiving ticagrelor

4 March 2018 (12:12 - 12:30)
Organised by:
Congress Presentation Part of: Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis Acute Coronary Syndromes: Antiplatelet Agents ACVC Premium Access Acute Cardiovascular Care 2018

ESC 365 is supported by

ESC 365 is supported by